OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
Yasser Fouad, Imam Waked, Steven Bollipo, et al.
Liver International (2020) Vol. 40, Iss. 6, pp. 1254-1261
Open Access | Times Cited: 269
Yasser Fouad, Imam Waked, Steven Bollipo, et al.
Liver International (2020) Vol. 40, Iss. 6, pp. 1254-1261
Open Access | Times Cited: 269
Showing 1-25 of 269 citing articles:
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai–Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 652
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai–Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 652
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin, Jiaofeng Huang, Ming-Fang Wang, et al.
Liver International (2020) Vol. 40, Iss. 9, pp. 2082-2089
Closed Access | Times Cited: 480
Su Lin, Jiaofeng Huang, Ming-Fang Wang, et al.
Liver International (2020) Vol. 40, Iss. 9, pp. 2082-2089
Closed Access | Times Cited: 480
MAFLD and risk of CKD
Dan‐Qin Sun, Yan Jin, Ting-Yao Wang, et al.
Metabolism (2020) Vol. 115, pp. 154433-154433
Open Access | Times Cited: 252
Dan‐Qin Sun, Yan Jin, Ting-Yao Wang, et al.
Metabolism (2020) Vol. 115, pp. 154433-154433
Open Access | Times Cited: 252
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
Santosh Kumar, Qihua Duan, Rongxue Wu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113869-113869
Closed Access | Times Cited: 229
Santosh Kumar, Qihua Duan, Rongxue Wu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113869-113869
Closed Access | Times Cited: 229
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
Mohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 10, pp. 864-873
Closed Access | Times Cited: 211
Mohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 10, pp. 864-873
Closed Access | Times Cited: 211
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. 2691-2700
Open Access | Times Cited: 197
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. 2691-2700
Open Access | Times Cited: 197
Reply to: correspondence regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”
Mohammed Eslam, Jacob George
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1575-1575
Open Access | Times Cited: 187
Mohammed Eslam, Jacob George
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1575-1575
Open Access | Times Cited: 187
NAFLD and liver transplantation: Disease burden, current management and future challenges
Patrizia Burra, Chiara Becchetti, Giacomo Germani
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100192-100192
Open Access | Times Cited: 182
Patrizia Burra, Chiara Becchetti, Giacomo Germani
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100192-100192
Open Access | Times Cited: 182
Redefining fatty liver disease: an international patient perspective
Gamal Shiha, Marko Korenjak, Wayne Eskridge, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 73-79
Closed Access | Times Cited: 163
Gamal Shiha, Marko Korenjak, Wayne Eskridge, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 73-79
Closed Access | Times Cited: 163
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
Jiaye Liu, Ibrahim Ayada, Xiaofang Zhang, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 3, pp. e573-e582
Open Access | Times Cited: 163
Jiaye Liu, Ibrahim Ayada, Xiaofang Zhang, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 3, pp. e573-e582
Open Access | Times Cited: 163
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 157
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 157
Quantification of Liver Fat Content with CT and MRI: State of the Art
Jitka Starekova, Diego Hernando, Perry J. Pickhardt, et al.
Radiology (2021) Vol. 301, Iss. 2, pp. 250-262
Open Access | Times Cited: 157
Jitka Starekova, Diego Hernando, Perry J. Pickhardt, et al.
Radiology (2021) Vol. 301, Iss. 2, pp. 250-262
Open Access | Times Cited: 157
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1069-1083
Open Access | Times Cited: 143
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
Л. Б. Лазебник, Е. В. Голованова, С. В. Туркина, et al.
Experimental and Clinical Gastroenterology (2021) Vol. 1, Iss. 1, pp. 4-52
Open Access | Times Cited: 123
Л. Б. Лазебник, Е. В. Голованова, С. В. Туркина, et al.
Experimental and Clinical Gastroenterology (2021) Vol. 1, Iss. 1, pp. 4-52
Open Access | Times Cited: 123
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
Θεόδωρος Ανδρουτσάκος, Narjes Nasiri‐Ansari, Athanasios‐Dimitrios Bakasis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3107-3107
Open Access | Times Cited: 98
Θεόδωρος Ανδρουτσάκος, Narjes Nasiri‐Ansari, Athanasios‐Dimitrios Bakasis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3107-3107
Open Access | Times Cited: 98
Metabolic Disorders in Menopause
Hye Gyeong Jeong, Hyuntae Park
Metabolites (2022) Vol. 12, Iss. 10, pp. 954-954
Open Access | Times Cited: 83
Hye Gyeong Jeong, Hyuntae Park
Metabolites (2022) Vol. 12, Iss. 10, pp. 954-954
Open Access | Times Cited: 83
The exposome and liver disease - how environmental factors affect liver health
Robert Barouki, Michel Samson, Étienne Blanc, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 492-505
Open Access | Times Cited: 75
Robert Barouki, Michel Samson, Étienne Blanc, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 492-505
Open Access | Times Cited: 75
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2844-2844
Open Access | Times Cited: 47
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2844-2844
Open Access | Times Cited: 47
Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
Qiannan Ren, Qiming Sun, Junfen Fu
Autophagy (2023) Vol. 20, Iss. 2, pp. 221-241
Open Access | Times Cited: 44
Qiannan Ren, Qiming Sun, Junfen Fu
Autophagy (2023) Vol. 20, Iss. 2, pp. 221-241
Open Access | Times Cited: 44
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 31
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 31
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
Gamal Shiha, Khalid Alswat, Maryam Al Khatry, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 57-64
Closed Access | Times Cited: 139
Gamal Shiha, Khalid Alswat, Maryam Al Khatry, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 57-64
Closed Access | Times Cited: 139
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
Nahúm Méndez‐Sánchez, Marco Arrese, Adrián Gadano, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 65-72
Closed Access | Times Cited: 137
Nahúm Méndez‐Sánchez, Marco Arrese, Adrián Gadano, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 65-72
Closed Access | Times Cited: 137
Pathophysiological mechanisms underlying MAFLD
Mohammad Shafi Kuchay, Narendra S. Choudhary, Sunil Kumar Mishra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 1875-1887
Closed Access | Times Cited: 118
Mohammad Shafi Kuchay, Narendra S. Choudhary, Sunil Kumar Mishra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 1875-1887
Closed Access | Times Cited: 118
History of Nonalcoholic Fatty Liver Disease
Amedeo Lonardo, Simona Leoni, Khalid Alswat, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5888-5888
Open Access | Times Cited: 117
Amedeo Lonardo, Simona Leoni, Khalid Alswat, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5888-5888
Open Access | Times Cited: 117
From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
Kenneth I. Zheng, Jian‐Gao Fan, Junping Shi, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 19, pp. 2271-2273
Open Access | Times Cited: 103
Kenneth I. Zheng, Jian‐Gao Fan, Junping Shi, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 19, pp. 2271-2273
Open Access | Times Cited: 103
